Ramiy Lidor-Hadas

Title: Ramiy Lidor-Hadas: Innovator in Pharmaceutical Chemistry

Introduction

Ramiy Lidor-Hadas is a notable inventor based in Kfar Saba, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of risedronate sodium. His innovative approach has led to advancements that benefit the medical community and patients alike.

Latest Patents

Ramiy holds a patent for "Risedronate sodium having a very low content of iron." This invention relates to a method of making risedronate sodium substantially free of iron. The process involves refluxing a combination of risedronic acid, a sodium base, and an iron-reducing amount of EDTA in a suitable liquid. The result is the isolation of risedronate sodium that is substantially free of iron, enhancing its efficacy and safety.

Career Highlights

Ramiy Lidor-Hadas is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on innovative solutions that address critical health issues. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, Ramiy has collaborated with talented professionals, including Nissm Sasson and Igor Lifshitz. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Ramiy Lidor-Hadas exemplifies the spirit of innovation in the pharmaceutical field. His contributions, particularly in the development of risedronate sodium, highlight the importance of research and collaboration in advancing healthcare solutions.